Ankyrin Repeat and SOCS Box Containing 8 (ASB8) (N-Term) Peptide
-
- Target See all ASB8 products
- ASB8 (Ankyrin Repeat and SOCS Box Containing 8 (ASB8))
- Protein Region
- N-Term
- Origin
- Human
-
Source
- Synthetic
- Application
- Blocking Peptide (BP), Western Blotting (WB)
- Characteristics
- This is a synthetic peptide designed for use in combination with anti-ASB8 antibody (Catalog #: ARP52408_P050). It may block above mentioned antibody from binding to its target protein in western blot and/or immunohistochecmistry under proper experimental settings. There is no guarantee for its use in other applications.
- Purification
- Purified
-
-
- Application Notes
- Each Investigator should determine their own optimal working dilution for specific applications.
- Restrictions
- For Research Use only
-
- Format
- Lyophilized
- Reconstitution
- Add 100 μL of sterile PBS. Final peptide concentration is 1 mg/mL in PBS.
- Concentration
- 1 mg/mL
- Buffer
- Final peptide concentration is 1 mg/mL in PBS.
- Handling Advice
- Avoid repeated freeze-thaw cycles.
- Storage
- -20 °C
- Storage Comment
- For longer periods of storage, store at -20°C. Avoid repeat freeze-thaw cycles.
-
- Target
- ASB8 (Ankyrin Repeat and SOCS Box Containing 8 (ASB8))
- Synonyms
- wu:fd16d08 Peptide, zgc:64033 Peptide, 4930539L19Rik Peptide, AI788835 Peptide, C430011H06Rik Peptide, ankyrin repeat and SOCS box containing 8 Peptide, ankyrin repeat and SOCS box-containing 8 Peptide, ASB8 Peptide, asb8 Peptide, Asb8 Peptide
- Background
-
ASB8 may be a substrate-recognition component of a SCF-like ECS (Elongin-Cullin-SOCS-box protein) E3 ubiquitin-protein ligase complex which mediates the ubiquitination and subsequent proteasomal degradation of target proteins.
Alias Symbols: FLJ21255, MGC5540, PP14212
Protein Interaction Partner: TCEB2,TCEB1,TCEB2
Protein Size: 288 - Molecular Weight
- 32 kDa
- Gene ID
- 140461
- NCBI Accession
- NM_024095, NP_077000
- UniProt
- Q9H765
-